Numerus Analytics Ag

What Numerus Analytics Ag does

Numerus Analytics Ag is a privately held statistical consulting firm founded in 2006, operating with a headcount of 11-50 employees. The company provides statistical consulting and analysis services across three core domains: clinical trials, health technology assessment (HTA), and real-world data (RWD) analytics. Its client base would logically include pharmaceutical sponsors, biotechnology companies, medical device firms, and HTA bodies requiring rigorous biostatistical expertise for regulatory submissions, reimbursement decisions, and evidence generation.

The firm's service portfolio centers on statistical methodology and data analysis rather than software product development. No proprietary technology platforms, productized software, or AI/ML capabilities were disclosed in available sources. The business model is consistent with a professional services / consulting structure — revenue derived from project-based engagements, retainers, or analytic service contracts rather than software licensing or subscription revenue. The company's "Ag" designation (Aktiengesellschaft) indicates incorporation under Swiss corporate law, and its website (numerus.com) serves as the primary digital presence.

There is no publicly available information regarding funding history, ownership structure, leadership team, customer logos, geographic footprint, partnerships, or financial performance. The firm's 18+ year operating history at a small headcount suggests a stable boutique consulting practice. The lack of disclosed growth signals — no funding rounds, acquisitions, product launches, or geographic expansions — indicates a measured, organic-growth posture typical of specialized independent consultancies serving regulated life sciences markets.

Name

Numerus Analytics Ag

Legal name

Numerus Analytics Ag

Website

https://numerus.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Numerus Analytics Ag is a Swiss-based statistical consulting firm, founded in 2006, providing biostatistical analysis services for clinical trials, health technology assessment, and real-world data to pharmaceutical, biotech, and HTA clients.

Ownership category

akta.pro rank

Product category

Biostatistics Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417), Custom Computer Programming Services (541511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

akta.pro secondary industries

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

• Clinical trial statistics
• Health technology assessment
• Real world data analysis
• Biostatistics consulting
• Pharmaceutical statistical services

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Core offering

Numerus Analytics Ag provides statistical consulting and analysis services focused on three core practice areas: clinical trials, health technology assessment (HTA), and real-world data (RWD). The firm delivers biostatistical expertise, study design support, evidence synthesis, and analytical output to support pharmaceutical, biotech, and healthcare decision-making across the product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Statistical Consulting Statistical consulting and analysis services supporting clinical trial design, analysis, and reporting for pharmaceutical and biotech sponsors.
• Health Technology Assessment (HTA) Analysis Statistical analysis and evidence synthesis services to support health technology assessment submissions and payer evidence requirements.
• Real-World Data (RWD) Analysis

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Broad incumbents

• IQVIA: IQVIA is the largest global CRO and RWE analytics provider; its biostatistics, real-world data, and evidence solutions overlap Numerus's full scope, although offered as part of a much wider services portfolio.
• Clario: Clario provides clinical trial endpoint technology and biostatistics/analytics services; an established incumbent that competes for the same biostatistics and clinical-data-analytics engagements as Numerus, with a broader technology footprint.
• Charles River Laboratories: Charles River Laboratories' CDMO and research services include biostatistics and clinical support, representing a scaled incumbent competing for portions of Numerus's addressable work, especially in European biotech sponsors.
• Parexel International: Parexel is a global CRO offering biostatistics, HTA, and real-world evidence services, overlapping Numerus's trials and HTA/RWE mix as part of a broad full-service portfolio.

Direct peers

• Cytel: Cytel is the most directly comparable biostatistics and clinical analytics consulting firm, providing statistical programming, adaptive design, and clinical data services to pharma sponsors — an essentially identical service mix to Numerus across trials and RWE.
• CROS NT: CROS NT is a statistical and data management CRO providing biostatistics, statistical programming, and CDISC services — a direct head-to-head comparable in size and service scope.
• Aixial Group: Aixial Group provides biostatistics, data management, and clinical operations services across Europe, directly competing for the European biopharma statistical consulting engagements Numerus targets.
• Berry Consultants: Berry Consultants provides specialized statistical design and analysis consulting for clinical trials, sharing Numerus's niche focus on expert biostatistics advisory rather than full CRO execution.
• Valid Insight: Valid Insight provides HTA, market access, and real-world evidence consulting, directly overlapping Numerus's HTA and RWD adjacencies.
• Phastar: Phastar is a statistical CRO offering biostatistics, statistical programming, and data science services for clinical trials, directly mirroring Numerus's core trial-statistics offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/numerus-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Numerus Analytics Ag